Showing 116 of 116on this page. Filters & sort apply to loaded results; URL updates for sharing.116 of 116 on this page
Immuron Multivitamin Syrup | 200ml - Selik Derma
Buy Immuron Cough Syrup Online | Ayurvedic Herbal Syrup
Immuron Receives FDA Approval for Travelan IND Application
IMMURON - Protectyn | Merge Health
Immuron Limited: A Biopharmaceutical Company Developing Polyclonal ...
Immuron by Protectyn 30 Capsules – Mr Vitamins
Immuron Cough Syrup Ayurvedic Natural Grace Health Care 100ml at ₹ 60 ...
Working at Immuron | Glassdoor
Immuron (ASX:IMC) Share Price News
Immuron investor hub
Immuron Limited - 1 1 AGM PRESENTATION 21 NOVEMBER , 2023 NASDAQ: IMRN ...
Calmino & Immuron Limited partner to bring ProIBS® to AUSTRALIA ...
Immuron secures around US$2 million in funding after lodging Form F-3 ...
Immuron working towards US FDA approval of Traveler’s Diarrhea product ...
Immuron (ASX:IMC / NASDAQ:IMRN) Investor Presentation - Business Update ...
ASX:IMC - Immuron launch PROIBS for IBS
Immuron (IMRN) Stock Price & Overview
Immuron IMM-529 IND approved by FDA - BioSpace
Immuron (ASX:IMC): Emerging ASX Gems presentation | Immuron
Immuron Limited - AnnualReports.com
Immuron posts steady global gains as Travelan drives third quarter ...
How the platform works - Immuron Limited
Immuron secures FDA approval for IMM-529 Investigational New Drug ...
Immuron takes aim at the rapid growth of autoimmune diseases
Immuron Limited (NASDAQ: IMRN) Revenue Grew 179% While Working to ...
Immuron (IMRN) Raises $8.5M for Biotech Expansion • BioTech Health X
Immuron marks surge in Travelan® sales on eve of entry into US via ...
Immuron confirms record sales and major clinical milestones ...
Immuron launches PROIBS in Australia to support people living with IBS ...
Immuron Submits IND to US FDA for novel therapy targeting C. difficile ...
Immuron grows revenue by 153% in H1 FY23 with more growth catalysts ...
Immuron (ASX:IMC) files FDA application for deadly C. diff infection fight
IMRN | Immuron Limited American Depositary Stock Data, Price & News
Immuron signs up second cohort for clinical trial assessing Travelan ...
Adding Immuron (IMRN) $2.57 to Superbug Watchlist. | Internet | Biotech ...
Immuron Limited (IMRN) Presents at Emerging Growth Conference 89 ...
Immuron (NASDAQ: IMRN), plans IND submission for CDI treatment in 2025
Immuron Stock Surged 58.3% As FDA Lifts Clinical Hold on ETEC
Immuron (ASX:IMC): Emerging ASX Gems presentation - YouTube
ASX Health Stocks: Immuron leaps 80pc after announcing that Travelan ...
Products - Immuron Limited
Immuron Receives FDA Approval for Travelan IND Application - DistilINFO ...
ASX:IMC - Immuron Continued Sales Growth
Immuron (ASX:IMC) looks toward pivotal Travelan trials
About - Immuron Limited
Immuron Limited Oral Immunoglobulins Changing the Paradigms - of Care ...
Immuron on How their Gastrointestinal and Digestive Health Immune ...
Immuron posts H1 Travelan sales of AUD$4.2m | IMRN SEC Filing - Form 6-K
Immuron Ltd (ASX:IMC) Share Price - Market Index
Immuron Presentation at RedChip's July 2016 Conference - YouTube
Immuron receives first USA orders for Travelan® - Australian Manufacturing
Immuron CEO to Present at Emerging Growth Conference | IMRN SEC Filing ...
Immuron (ASX:IMC): Developing & commercialising a novel class of ...
Immuron seeks approval for prior share issues | IMRN SEC Filing - Form 6-K
Pipeline - Immuron Limited
Technology - Immuron Limited
ProIBS® (10 Pack) - Immuron Limited
Immuron enrols first patients into Phase 2 trials for treatment to ...
Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)
ProIBS® (30 Pack) - Immuron Limited
Immuron on LinkedIn: #asx #imc #nasdaq #imrn #travel #health
Immuron Skyrockets after Clinical Hold Lift on Diarrhea Candidate by ...
Immuron Limited received FDA approval for Travelan IND Application ...
An excellent update from Immuron (ASX: IMC) on their Travelan sales for ...
Immuron appoints new non executive chairman | Careers | POST Online Media
Immuron secures new U.S. DoD award for Campylobacter, Shigella | IMRN ...
Immuron Ltd readies for traveller’s diarrhoea-targeted clinical trial ...
Immuron flushed with success | The Australian
Immuron and Monash University Join Forces to Combat Antimicrobial ...
📰 Member news 🦠 Immuron has enrolled its first cohort of 30 ...
Immuron Limited
My Company - Immuron
Immuron Updates on Clinical Trials for Travelan and IMM-529 - Investors ...
ASX:IMC - Immuron receives R&D Tax Incentive
Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS ...
FDA Lifts Clinical Hold From Immuron's New Campylobacter ETEC ...
Imuron - Immune Formula – REX Genetics, USA
Emerging Growth Conference 79 - EmergingGrowth.com
Immuron, IMRN, up 71% - The FDA really, really, matters to pharma ...
Immuron's innovations in gastrointestinal immunotherapy paying off ...
IMM - 124E Revolutionary Treatment for NASH
Immuron’s commercially available products found to neutralise COVID-19 ...
Immuron's antibody platform pioneers new approach to gastro-intestinal ...
FDA Clears Immuron’s IMM-529 For Clinical Testing in C difficile; Phase ...
Logistics 360
(IMMURON LOGO)
Lifecycle Management in the Pharmaceutical Industry | PPT
Aimmune Logo American Biopharmaceutical Company Aimmune Stock Photo ...
ASX:IMC - Appendix 4D and Half Year Report
Immuron: Targeted oral antibodies to treat infectious diseases
Immuron's Travelan sales growth, clinical pipeline achievements and ...
Immuron's Groundbreaking Defense Award and Clinical Advances ...
[IMRN] 이뮤론 ADR Immuron, 호주와 미국을 포함한 전 세계적으로 Travelan® 판매 신기록 수립 발표 ...
Licensing Technologies - Hadasit - Health Innovation Engine
Protectyn Home | Protectyn | Digestive Function & Liver Support Supplement
